Market Cap (In USD)
27.41 Million
Revenue (In USD)
-
Net Income (In USD)
-31.47 Million
Avg. Volume
6168.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.11-28.68
- PE
- -
- EPS
- -
- Beta Value
- 1.455
- ISIN
- US34962G1094
- CUSIP
- 34962G109
- CIK
- 1419041
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Paul A. Wagner Ph.D.
- Employee Count
- -
- Website
- https://www.fortebiorx.com
- Ipo Date
- 2017-04-13
- Details
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More Stocks
-
MKG
-
MARK
-
HBT
-
007310Ottogi Corporation
007310
-
BKLRFBerkeley Energia Limited
BKLRF
-
CPL
-
000025
-
WLRMFAloro Mining Corp.
WLRMF